intellectual property


Trump is right: Nafta is a disaster. But US workers aren’t the big losers
The president-elect has promised to rip up the free trade treaty, yet there is no sign that his approach will be any fairer
UK and India sign wide-ranging IP agreement
The countries will exchange best practices in the IP field, such as streamlining the processing of patent, trademark and design registrations.
What do trade agreements do for open access—and what don't they do?
The absence of support for open access in trade agreements comes as no surprise when considering that there are no representatives from the education sector, nor any library or archive representatives, in the relevant closed-door trade advisory committees
Call for Govt to help our neighbours negotiate for life-saving medicines
The Public Health Association (PHA) is asking the NZ government to step in and help our neighbouring countries negotiate better deals for life-saving medicines.
India to US: Will not tighten IPR rules beyond TRIPS mandate
India and the US continued to differ on the issue of intellectual property rights (IPR) norms in their bilateral trade and investment policy discussions
Activists fret about RCEP impact
Access to affordable medicine and farmers' control over seeds could be undermined by the Regional Comprehensive Economic Partnership being negotiated between Asean member countries and six other trade partners, says FTA Watch in Thailand
An open letter to the sixteen governments negotiating the Regional Comprehensive Economic Partnership (RCEP)
95 health, community and development organisations in the Asia Pacific region call on trade negotiators from sixteen countries in the Regional Comprehensive Economic Partnership agreement negotiations to ensure access to medicines is protected. We the undersigned organisations call on negotiators to protect health and reject all TRIPS plus intellectual property measures in the RCEP.
Open letter to ambassadors (in India) of RCEP negotiating countries by Delhi Network of Positive People
Member countries must consider the impact of RCEP on access to medicines in developing countries
The Aids revolution is why Asean, India and China must resist controls on generic drugs
Affordable generics have transformed medical treatment, yet intellectual property provisions in a China-led regional trade deal could block access to life-saving drugs for millions in Africa and Asia
In boon for Big Pharma, TTIP would lock in high drug prices: report
'Unfortunately, trade agreements have become one more mechanism for drug corporations to expand their monopoly power'